Collectively, these data indicate that there exists a feedback modulation between Cx43 expression and PI3K/Akt pathway, retarding Cx43 expression and activating PI3K/Akt signaling, subsequently contributing to EMT and TAM resistance in breast cancer. This evidence concerns the gene AKT1 and breast cancer.